Squarepoint’s Calumet Specialty Products CLMT Stock Holding History

Squarepoint’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,200	Closed	-$291K	–	4679
2024 Q4	$291K	Buy	+13,200	New	+$278K	﹤0.01%	4170

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Squarepoint's CLMT Position: Q4 2025 in Review

Squarepoint sold out of Calumet Specialty Products (CLMT) in Q4 2025, closing a stake of 23,999 shares — an estimated $462K sold.

Squarepoint first reported a position in CLMT in Q4 2024 and held it in 3 quarters. The position peaked at $500K in Q2 2025. 140 funds tracked by Wall St. Rank hold CLMT as of Q4 2025.

Squarepoint reported no remaining Calumet Specialty Products position as of Q4 2025 after selling out during the quarter.
Squarepoint sold 23,999 Calumet Specialty Products shares in Q4 2025, an estimated $462K.
Squarepoint first reported a position in Calumet Specialty Products in Q4 2024 and held it in 3 quarters.
Squarepoint's Calumet Specialty Products position peaked at $500K in Q2 2025.
140 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.